Project Grant R21EY038865
- Federal Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded The Johns Hopkins University a $695,018 Project Grant effective August 1, 2025, through July 31, 2030, to conduct research on the regulation of retinal ganglion cell regeneration through Müller glia (MG) cell function. The award supports a five-year investigation into how MG cells function as injury-responsive stem cells to enable retinal regeneration, with the ultimate goal...
- Federal Grant Award Summary The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded a $682,679 Project Grant to The Johns Hopkins University effective July 1, 2026, through January 31, 2030. This research initiative focuses on identifying drivers of retinal ganglion cell (RGC) differentiation from endogenous stem cells—a critical area given that RGCs are the sole neurons capable of relaying visual information from the retina to the brain, and their loss can...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded Harvard Medical School a Project Grant totaling $464,750 under the Vision Research program (CFDA 93.867) beginning September 1, 2025, with completion scheduled for August 31, 2027. This award supports research to understand how lineage contributes to cell diversity in the chicken retina, particularly in the high acuity area. The primary research deliverables include the adaptation and validation of SCRIBBLE, a novel lineage...
- This project grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports fundamental research into photoreceptor patterning and cell fate specification in fruit flies and mosquitoes. The $223,248 award to Johns Hopkins University, effective from September 15, 2025 through August 31, 2027, funds research that will advance understanding of how sensory neurons differentiate into distinct subtypes during retinal development. The investigator will generate...
- Summary The University of Rochester received a $684,914 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective July 1, 2026, through March 31, 2030. The award funds development of human induced pluripotent stem cell (hiPSC)-derived retinal tissue models to address the critical shortage of physiologically relevant human retina cell systems for disease modeling and therapeutic research. Retinal diseases account for over 54% of blindness in...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded The Johns Hopkins University a $110,228 Project Grant on February 12, 2027, under the Vision Research program (CFDA 93.867) to support basic neuroscience research investigating cerebellar mechanisms of oculomotor learning. The research will be conducted in Baltimore, Maryland, with a completion date of June 30, 2029. The project aims to elucidate how the oculomotor vermis of the cerebellum—specifically through...
- Federal Grant Award Summary Funding Agency: National Eye Institute (NEI), National Institutes of Health Federal Grant Program: Vision Research (CFDA 93.867) Award Amount: $100,228.00 Award Date: December 1, 2026 Performance Period: December 1, 2026 – April 29, 2029 Awardee: The Trustees of Columbia University in the City of New York Columbia University is conducting preclinical research to develop and validate an autologous stem cell transplantation therapy for autosomal dominant retinal...
- Federal Project Grant Award Summary The National Eye Institute (NEI) awarded a $701,576 Project Grant to the University of California, San Diego, effective July 1, 2026, through April 30, 2030, under the Vision Research program (CFDA 93.867). The award funds research to explore endogenous retinal ganglion cell (RGC) repair mechanisms following injury using engineered human pluripotent stem cell (PSC)-derived three-dimensional retinal organoids as a model system. The research addresses the...
- Federal Project Grant Award Summary Award Details: The National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), awarded the University of Chicago a Project Grant of $929,806 on September 30, 2025, with an ultimate completion date of September 29, 2027. Research Deliverables: This award funds research on synaptic development of the retinogeniculate pathway—the neural circuit connecting the eyes to the brain. The research employs newly developed technology to directly observe...
- Federal Project Grant Award Summary Baylor College of Medicine received a $1.6 million Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), awarded September 30, 2025, with completion targeted for September 29, 2028. This research grant supports basic science investigation into the Hippo and Wnt signaling pathway regulation of mammalian Müller glial cell (MG) reprogramming and proliferation. The project seeks to identify cellular and molecular...
The National Eye Institute (NEI) awarded a $427,504 Project Grant to The Johns Hopkins University effective July 1, 2026 through June 30, 2028 under the Vision Research program (CFDA 93.867). The award funds the development and validation of BLAB-SEQ (Birth Labeled Sequencing), a novel transgene-based methodology that combines non-toxic fluorescent birth dating with single-cell RNA sequencing to directly link neuronal birth timing and fate specification in human organoids. Unlike existing chemical-based birth dating strategies that are cytotoxic and incompatible with transcriptomic profiling, BLAB-SEQ provides a temporally precise, non-toxic approach capable of identifying birth dates and gene expression profiles across diverse neuronal subtypes in living tissue, addressing critical gaps in understanding how cell cycle exit timing determines neuronal fate during development. The research team will validate BLAB-SEQ using human retinal organoids to generate mechanistic insights into retinal neurogenesis, establishing developmental timelines for the seven major retinal cell classes and characterizing the birth timing of approximately 130 retinal cell subtypes—data currently unavailable for human systems. These deliverables will advance fundamental understanding of human retinal development and provide the scientific community with a broadly applicable platform technology for studying neurogenesis across multiple human organoid types and tissues.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $427.5k | 7/1/26 |